Skip to main content
OpenTrials

Clinical trial condition

Non-Hodgkin's Lymphoma

Explore clinical trials studying Non-Hodgkin's Lymphoma. Study availability and eligibility vary by location and protocol.

250 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Non-Hodgkin's Lymphoma trial results

Completed

Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT01767766

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +22 more
Locations
  • TG Therapeutics Trial Site Sarasota, Florida, United States
  • TG Therapeutics Trial Site Hackensack, New Jersey, United States
  • TG Therapeutics Trial Site New York, United States
  • TG Therapeutics Trial Site Durham, North Carolina, United States
View Trial Details
Completed

A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT01594229

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Ucsd /Id# 67350 La Jolla, California, United States
  • University of California, Los Angeles /ID# 67343 Los Angeles, California, United States
  • Emory University Hospital /ID# 67349 Atlanta, Georgia, United States
  • Georgia Regents University /ID# 67342 Augusta, Georgia, United States
View Trial Details
Completed

A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies

NCT00406809

Conditions
Chronic Lymphoid Leukemia, Follicular Lymphoma, Hematologic Diseases, +25 more
Locations
  • Site Reference ID/Investigator# 4997 Los Angeles, California, United States
  • Site Reference ID/Investigator# 9104 Los Angeles, California, United States
  • Site Reference ID/Investigator# 2613 Bethesda, Maryland, United States
  • Site Reference ID/Investigator# 40243 Boston, Massachusetts, United States
View Trial Details

Related conditions